TrialDiabetes, obesity & metabolism2021

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.

Mark Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.